Drug Trial Radar · NCT05785754
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Last checked: Nov 20, 2026Latest source record: Jun 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Jun 28, 2023
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- DynamiCure BiotechnologyIndustry
- Sponsor type
- Industry
- First posted
- Mar 27, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open-label, Phase 1 study to assess the effects of DCSZ11 as a monotherapy and in combination in patients with advanced or metastatic solid tumors. The study consists of an Escalation Phase (Phase 1a) and a Dose Expansion/Optimization Phase (Phase 1b).
Conditions
- Advanced or Metastatic Solid Tumors
Interventions
DCSZ11Drug
A monoclonal antibody that binds to CD93, DCSZ11 will be administered as a single intravenous (IV) infusion on Day 1 in each 21-day cycle.
PembrolizumabDrug
Pembrolizumab injection
DoxorubicinDrug
1b SOC Cohort 1: Doxorubicin combination in soft tissue sarcoma
TebentafuspDrug
1b SOC Cohort 2: Tebentafusp combination in uveal melanoma
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1a: Incidence of dose limiting toxicites (DLTs)Time frame: 21 days
- Phase 1a: Frequency and severity of treatment emergent adverse eventsTime frame: up to 3 years
- Phase 1b: Overall response rate (ORR) per Investigator-assessed Response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST)Time frame: 1 year
Locations
35 sites in 4 countries. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama · Recruiting
Mayo Clinic
Phoenix, Arizona · Recruiting
HonorHealth
Scottsdale, Arizona · Recruiting
University of Colorado
Aurora, Colorado · Recruiting
Sarah Cannon Research Institute Denver Healthone
Denver, Colorado · Recruiting
Yale Cancer Center
New Haven, Connecticut · Recruiting
Mayo Clinic
Jacksonville, Florida · Recruiting
University of Miami
Miami, Florida · Recruiting
John Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Completed
Mayo Clinic
Rochester, Minnesota · Recruiting
MonteFiore
The Bronx, New York · Recruiting
Ohio State University
Columbus, Ohio · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Townsville Hospital
Douglas, Australia · Recruiting
Liverpool Hospital
Liverpool, Australia · Completed
Mater Misericordiae Health Services Brisbane Ltd
South Brisbane, Australia · Recruiting
Sydney Adventist Hospital
Wahroonga, Australia · Withdrawn
Scientia Clinical Research
Randwick, New South Wales, Australia · Recruiting
St Vincent's Hospital
Sydney, New South Wales, Australia · Recruiting
University of Sunshine Coast
Buderim, Queensland, Australia · Withdrawn
Southern Oncology Clinical Research Unit (SOCRU)
Bedford Park, South Australia, Australia · Recruiting
The Queen Elizabeth Hospital (TQEH)
Woodville South, South Australia, Australia · Recruiting
Monash Health
Clayton, Victoria, Australia · Recruiting
Cabrini Hospital
Malvern, Victoria, Australia · Completed
Linear Clinical Research Limited
Nedlands, Western Australia, Australia · Recruiting
Inje University Haeundae Paik Hospital
Busan, South Korea · Recruiting
Dong-a University Hospital
Busan, South Korea · Recruiting
Cha University Bundang Medical Center
Gyeonggi-do, South Korea · Recruiting
Severance Hospital, Yonsei University Health System
Seoul, South Korea · Recruiting
Asan Medical Center
Seoul, South Korea · Withdrawn
Kaohsiung Medical University Chung-ho Memorial Hospital
Kaohsiung City, Taiwan · Recruiting
National Cheng Kung University Hospital
Tainan, Taiwan · Recruiting
Taipei Veterans General Hospital
Taipei, Taiwan · Recruiting
National Taiwan University Hospital
Taipei, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.